THC GLOBAL GROUP LIMITED Details
THC operates under a ‘farm to pharma’ pharmaceutical model and is currently delivering high quality medicinal cannabis products to Australian patients through existing access schemes. Having secured both a significant growing capacity over two grow sites, and an industry-leading pharmaceuticals biomanufacturing facility, THC is in prime position to service both domestic patients and the export market.
THC also operates a revenue generating global hydroponics business, focusing on the manufacturing and distribution of hydroponics equipment, materials, and nutrients.
| Issuer code | THC |
|---|---|
| Official listing date | 04/05/2017 |
| GICS industry group | Pharmaceuticals, Biotechnology & Life Sciences |
| Exempt foreign? | No |
| Internet address | thc.global |
| Registered office address | Suite 4102, Level 41, 264 George Street, SYDNEY, NSW, AUSTRALIA, 2000 |
| Head office telephone | 02 8088 4760 |
| Head office fax | – |
| Share registry | COMPUTERSHARE INVESTOR SERVICES PTY LIMITED YARRA FALLS, 452 JOHNSTON STREET, ABBOTSFORD, VIC, AUSTRALIA, 3067 |
| Share registry telephone | 1300 787 272 |
Directors/Senior management
| Mr Steven Xu | Non Exec. Chairman, Non Exec. Director |
|---|---|
| Mr Ken Charteris | Chief Executive Officer |
| Mr Alan Preston Beasley | Non Exec. Director |
| Mr Lou Cattelan | Non Exec. Director |
| Mr Gary Radcliff | Non Exec. Director |
| Mr Jarrod White | Chief Financial Officer |
Company Secretary
| Mr Henry Kinstlinger | |
|---|---|
